105 related articles for article (PubMed ID: 21618953)
1. The real CER: lost in translation.
Pearson S
Oncology (Williston Park); 2011 Apr; 25(4):320, 323. PubMed ID: 21618953
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness, cancer burden and financial crisis: a perfect storm.
Belda-Iniesta C
Clin Transl Oncol; 2012 Oct; 14(10):713-4. PubMed ID: 22996423
[No Abstract] [Full Text] [Related]
3. Budget cuts in the USA: a short-term win?
Lancet Oncol; 2012 Jan; 13(1):1. PubMed ID: 22225713
[No Abstract] [Full Text] [Related]
4. The war on cancer: progress at what price?
Konski A
J Clin Oncol; 2011 Apr; 29(12):1503-4. PubMed ID: 21402613
[No Abstract] [Full Text] [Related]
5. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
Ramsey SD
J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
[No Abstract] [Full Text] [Related]
6. Value in Oncology: Balance Between Quality and Cost.
Raghavan D; Legnini MW
Am Soc Clin Oncol Educ Book; 2016; 35():9-13. PubMed ID: 27249680
[No Abstract] [Full Text] [Related]
7. "Come Home": A Medicare Innovation Center project.
McAneny BL
Oncology (Williston Park); 2012 Dec; 26(12):1145, 1156. PubMed ID: 23413590
[No Abstract] [Full Text] [Related]
8. Cost effectiveness, chemotherapy, and the clinician.
Griggs JJ; Sorbero ME
Breast Cancer Res Treat; 2009 Apr; 114(3):597-8. PubMed ID: 18695985
[No Abstract] [Full Text] [Related]
9. [Methodology of economic assessment: example in oncology].
Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
[TBL] [Abstract][Full Text] [Related]
10. Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer Research.
Vose JM
Oncology (Williston Park); 2015 Sep; 29(9):613, 615. PubMed ID: 26391037
[No Abstract] [Full Text] [Related]
11. Cost, coverage, and comparative effectiveness research: the critical issues for oncology.
Pearson SD
J Clin Oncol; 2012 Dec; 30(34):4275-81. PubMed ID: 23071229
[TBL] [Abstract][Full Text] [Related]
12. Managing oncology costs.
Reeder CE; Gordon D
Am J Manag Care; 2006 Feb; 12(1 Suppl):S3-16; quiz S17-9. PubMed ID: 16478368
[TBL] [Abstract][Full Text] [Related]
13. The future of surgical oncology.
Weese JL
Adm Radiol J; 1997; 16(2-3):12-7. PubMed ID: 10173074
[No Abstract] [Full Text] [Related]
14. Opaque Results of Federal Price Transparency Rules and State-Based Alternatives.
Kircher SM; Royce TJ; Upadhyay D; Polite BN
J Oncol Pract; 2019 Sep; 15(9):463-464. PubMed ID: 31403893
[No Abstract] [Full Text] [Related]
15. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
Freeman RA
J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
[No Abstract] [Full Text] [Related]
16. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
Lyman GH
Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
[No Abstract] [Full Text] [Related]
17. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
18. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
[No Abstract] [Full Text] [Related]
19. Cost of cancer care: issues and implications.
Meropol NJ; Schulman KA
J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
[TBL] [Abstract][Full Text] [Related]
20. Interpreting the economic literature in oncology.
Grusenmeyer PA; Wong YN
J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
